论文部分内容阅读
GMP的提出是为了保证药品生产安全,保证药品安全是GMP的中心理念。自实施GMP以来,药品安全状况有了明显的改善,但是部分已经获得GMP证书的企业由于在通过认证之后的生产活动中违反了相关法律法规,GMP证书又被收回。截止到2015年12月25日,2015年药品监督管理部门共收回140家企业的GMP证书,约占到药品生产企业(含中药饮片和医用氧)的19.58‰,证书收回又发放的为60家,而其余80家企业没有发放,约占药品生产企业的11.19‰,为收回总数的57.14%。
GMP is proposed in order to ensure the safety of drug production, to ensure drug safety is the central idea of GMP. Since the implementation of GMP, the safety of medicines has been significantly improved. However, some enterprises that have obtained GMP certificates have also been withdrawn because of violation of relevant laws and regulations in their production activities after passing the certification. As of December 25, 2015, the drug regulatory authorities in 2015 collected a total of 140 GMP certificates from enterprises, accounting for 19.58% of the total number of pharmaceutical manufacturers (including Pieces of Chinese Herbal Medicine and Medical Oxygen) and 60 certificates of withdrawal , While the remaining 80 companies did not pay, accounting for 11.19 ‰ of pharmaceutical production enterprises, 57.14% of the total number of recovery.